These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37068406)

  • 1. Survival in melanoma in the nordic countries into the era of targeted and immunological therapies.
    Tichanek F; Försti A; Hemminki A; Hemminki O; Hemminki K
    Eur J Cancer; 2023 Jun; 186():133-141. PubMed ID: 37068406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years.
    Tichanek F; Försti A; Hemminki O; Hemminki A; Hemminki K
    Cancer Epidemiol; 2024 Oct; 92():102449. PubMed ID: 37679266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional survival in breast cancer up to 10 years in the Nordic countries.
    Zitricky F; Försti A; Hemminki A; Hemminki K
    Cancer Med; 2023 Sep; 12(17):17945-17951. PubMed ID: 37578395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies.
    Lundberg FE; Birgisson H; Engholm G; Ólafsdóttir EJ; Mørch LS; Johannesen TB; Pettersson D; Lambe M; Seppä K; Lambert PC; Johansson ALV; Hölmich LR; Andersson TM
    Eur J Cancer; 2024 May; 202():113980. PubMed ID: 38452724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific survival trends and life-years lost in women with breast cancer 1990-2016: the NORDCAN survival studies.
    Lundberg FE; Kroman N; Lambe M; Andersson TM; Engholm G; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Lambert PC; Mørch LS; Johansson ALV
    Acta Oncol; 2022 Dec; 61(12):1481-1489. PubMed ID: 36542678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival trends in solid cancers in the Nordic countries through 50 years.
    Hemminki J; Försti A; Hemminki A; Hemminki K
    Eur J Cancer; 2022 Nov; 175():77-85. PubMed ID: 36096040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major improvement in thyroid cancer survival of elderly patients in the Nordic countries.
    Zitrický F; Koskinen A; Liska V; Försti A; Hemminki A; Hemminki K
    Eur J Endocrinol; 2024 Mar; 190(3):K32-K36. PubMed ID: 38436478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019.
    Karttunen E; Hervonen P; Hosseini Aliabad A; Oldenburg J; Pappot H; Sairanen J; Støvring H; Vásquez JL; Bergman S; Magnussen G; Norremark P; Thoresen S; Ullén A
    Scand J Urol; 2023; 57(1-6):15-21. PubMed ID: 36416403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast.
    Hemminki K; Försti A; Hemminki O; Liska V; Hemminki A
    Int J Cancer; 2022 Jul; 151(2):200-208. PubMed ID: 35213036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in gastric and esophageal cancers in the Nordic countries through a half century.
    Hemminki K; Tichanek F; Försti A; Hemminki O; Hemminki A
    Cancer Med; 2023 May; 12(9):10212-10221. PubMed ID: 36846972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries.
    Nikkilä R; Haapaniemi A; Carpén T; Pukkala E; Mäkitie A
    Acta Oncol; 2024 Aug; 63():612-619. PubMed ID: 39099322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.
    Lundberg FE; Andersson TM; Lambe M; Engholm G; Mørch LS; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Johansson ALV; Lambert PC
    Acta Oncol; 2020 Nov; 59(11):1266-1274. PubMed ID: 33073632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.
    Hemminki K; Kanerva A; Försti A; Hemminki A
    BMC Cancer; 2022 Apr; 22(1):456. PubMed ID: 35473606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century.
    Tichanek F; Försti A; Liska V; Hemminki A; Hemminki K
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765946
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Bray F; Klint A; Hakulinen T; Storm HH; Engholm G
    Acta Oncol; 2010 Jun; 49(5):624-31. PubMed ID: 20429724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early mortality critically impedes improvements in thyroid cancer survival through a half century.
    Tichanek F; Försti A; Liska V; Hemminki O; Koskinen A; Hemminki A; Hemminki K
    Eur J Endocrinol; 2023 Sep; 189(3):355-362. PubMed ID: 37675794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.
    Hemminki K; Försti A; Chen T; Hemminki A
    BMC Cancer; 2021 Nov; 21(1):1189. PubMed ID: 34749677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.
    Johansson ALV; Kønig SM; Larønningen S; Engholm G; Kroman N; Seppä K; Malila N; Steig BÁ; Gudmundsdóttir EM; Ólafsdóttir EJ; Lundberg FE; Andersson TM; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
    Acta Oncol; 2024 Apr; 63():179-191. PubMed ID: 38597666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Use of BRAF Targeting Therapy in the Immunotherapy Era.
    Wood K; Luke JJ
    Curr Oncol Rep; 2016 Nov; 18(11):67. PubMed ID: 27613168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.